National Center for Research Resources (NCRR): Hematologic Diseases trials
The registry lists 12 Hematologic Diseases studies with National Center for Research Resources (NCRR) as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 4Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia MajorCompletedNCT00006138
- Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX DeficiencyCompletedNCT00004801Phase 1/2
- Pilot Study of Fructose for Sickle Cell CrisisCompletedNCT00004797Not applicable
- Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesCompletedNCT00004787Phase 2
- Phase I Study of Human Von Willebrand Factor for Von Willebrand's DiseaseCompletedNCT00004667Phase 1
- Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic TelangiectasiaCompletedNCT00004654Phase 3
- Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia PatientsCompletedNCT00004649
- Studies of Hereditary Hemorrhagic TelangiectasiaCompletedNCT00004648
- Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
- International Registry for Severe Chronic NeutropeniaStatus unknownNCT00004342
- Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile EctasiaCompletedNCT00004327Phase 2
- Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic AnemiaCompletedNCT00004323Phase 2